Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
216 hedge funds and large institutions have $2.6B invested in Amedisys in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 63 increasing their positions, 78 reducing their positions, and 22 closing their positions.
109% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 22
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
87% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $6.84M
31% more capital invested
Capital invested by funds: $1.99B → $2.6B (+$611M)
11% more funds holding
Funds holding: 194 → 216 (+22)
7.76% less ownership
Funds ownership: 97.24% → 89.48% (-7.8%)
19% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 78
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$108M |
| 2 |
BlackRock
New York
|
+$27.7M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$23.1M |
| 4 |
JP Morgan Chase
New York
|
+$14.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$14.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$178M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$46.2M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$28.8M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$22.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$21.6M |
AMED Hedge Fund Activity: Q2 2018 in Review
216 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2018, worth a combined $2.6B — up 31% from $1.99B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new AMED positions and 22 closed out — a net gain of 24 holders — while 63 added to existing stakes and 78 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $108M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $178M.
- 216 institutional investors held Amedisys (AMED) as of Q2 2018, up from 194 in Q1 2018.
- Funds reported $2.6B of Amedisys stock for Q2 2018, up 31% quarter-over-quarter.
- 46 funds opened new Amedisys positions in Q2 2018 and 22 closed out, a net change of +24 holders.
- The largest Amedisys buyer in Q2 2018 was Wellington Management Group, an estimated $108M added.
- The largest Amedisys seller in Q2 2018 was Kohlberg Kravis Roberts & Co, an estimated $178M sold.
Based on aggregated 13F filings for Q2 2018.